Deamidated gliadin peptide‐IgG (DGP‐IgG) antibody serology testing is widely utilised in screening for coeliac disease in Australia; however, it is used sparingly in Europe. The aim of this study was… Click to show full abstract
Deamidated gliadin peptide‐IgG (DGP‐IgG) antibody serology testing is widely utilised in screening for coeliac disease in Australia; however, it is used sparingly in Europe. The aim of this study was to assess the diagnostic value of a positive DGP‐IgG in the setting of a negative tissue transglutaminase‐IgA (tTG‐IgA) for gastrointestinal pathology among paediatric patients.
               
Click one of the above tabs to view related content.